SCHEMBL845533

SCHEMBL845533

CCCCOCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)COCCOC)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
LMNA P02545 2/20 0.46
PABPC1 P11940 1/20 0.45
MAPK1 P28482 2/20 0.45
ALDH1A1 P00352 1/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TSHR P16473 1/20 0.43
EP300 Q09472 4/20 0.42
CREBBP Q92793 4/20 0.42
GAA P10253 1/20 0.41
NAMPT P43490 1/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844900 0.95 CYP2C9 (0.47) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL845206 0.86 CYP2C9 (0.52) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL845251 0.80 PABPC1 (0.50) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL10119687 0.77 CYP2C9 (0.44) CYP2C9CYP2C19PABPC1MAPK1ALDH1A1
SCHEMBL845258 0.77 MAPK1 (0.60) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL844899 0.76 NPC1 (0.52) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL845295 0.76 KDM4E (0.61) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL845228 0.76 HCRTR1 (0.49) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL844882 0.76 PABPC1 (0.59) CYP2C9CYP2C19LMNAPABPC1MAPK1
SCHEMBL2195785 0.76 CYP2C9 (0.41) CYP2C9CYP2C19LMNAPABPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed